{"recordsFiltered":48486,"recordsTotal":48486,"next":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=38400","previous":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=37800","results":[{"registry_id":"NCT04722029","publication_url":"https://clinicaltrials.gov/study/NCT04722029","title":"Open-Label Pilot Study of Haploidentical Donor Adenovirus Specific T Lymphocytes (ADV-VSTS) for the Treatment of Refractory Adenovirus Infection and/or Disease in Hospitalized Patients","has_exemption":false,"start_date":"2021-10-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05038527","publication_url":"https://clinicaltrials.gov/study/NCT05038527","title":"ABM/P-15 Bone Graft vs Traditional Bone Graft in Adult Spinal Deformity Surgery - a Randomized Controlled Clinical Trial","has_exemption":false,"start_date":"2021-10-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Rigshospitalet, Denmark","sponsor_slug":"rigshospitalet-denmark","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04486352","publication_url":"https://clinicaltrials.gov/study/NCT04486352","title":"A Phase IB/II Multi-Cohort Study of Targeted Agents and/or Immunotherapy With Atezolizumab for Patients With Recurrent or Persistent Endometrial Cancer","has_exemption":false,"start_date":"2021-10-20","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Alliance Foundation Trials, LLC.","sponsor_slug":"alliance-foundation-trials-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04812925","publication_url":"https://clinicaltrials.gov/study/NCT04812925","title":"A Phase 3, Multicenter, Open-Label, Long-Term Trial to Evaluate the Safety and Efficacy of Efgartigimod (ARGX-113) PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia","has_exemption":false,"start_date":"2021-11-17","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05230537","publication_url":"https://clinicaltrials.gov/study/NCT05230537","title":"A Randomized, Participant and Investigator Masked, Placebo-controlled, Multicenter, Proof-of-concept Study to Assess the Safety and Efficacy of LNP023 (Iptacopan) in Patients With Early and Intermediate Age-related Macular Degeneration","has_exemption":false,"start_date":"2022-02-17","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04577755","publication_url":"https://clinicaltrials.gov/study/NCT04577755","title":"A Multicenter Phase II Study of Pomalidomide Monotherapy in Kaposi Sarcoma","has_exemption":false,"start_date":"2022-03-18","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05368844","publication_url":"https://clinicaltrials.gov/study/NCT05368844","title":"Harnessing Neurostimulation to Improve Treatment Outcome in Anorexia Nervosa","has_exemption":false,"start_date":"2022-06-16","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05558904","publication_url":"https://clinicaltrials.gov/study/NCT05558904","title":"Positron-Emission Tomography Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer","has_exemption":false,"start_date":"2023-01-19","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04682652","publication_url":"https://clinicaltrials.gov/study/NCT04682652","title":"GRAVITY: Genicular Artery Embolization Versus Observation for the Treatment of Symptomatic Knee Osteoarthritis: a Randomized Controlled Trial","has_exemption":false,"start_date":"2023-08-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05642455","publication_url":"https://clinicaltrials.gov/study/NCT05642455","title":"A Phase 1/2 Open Label, Basket Study to Assess the Safety, Tolerability and Anti-Tumor Activity of Afamitresgene Autoleucel in Pediatric Subjects With MAGE-A4 Positive Tumors","has_exemption":false,"start_date":"2023-09-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"USWM CT, LLC","sponsor_slug":"uswm-ct-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04713046","publication_url":"https://clinicaltrials.gov/study/NCT04713046","title":"A Phase I Clinical Trial Assessing the Safety, Feasibility and Immunologic Correlates of Allogeneic HPV-specific Cluster of Differentiation 4 (CD4)+ T Cells in Advanced HPV16-associated Malignancies","has_exemption":false,"start_date":"2023-10-18","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06052176","publication_url":"https://clinicaltrials.gov/study/NCT06052176","title":"Randomized Clinical Trial in Hepatic Encephalopathy to Study Lasting Cognitive Improvement With Intravenous Albumin","has_exemption":false,"start_date":"2023-11-02","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Hunter Holmes Mcguire Veteran Affairs Medical Center","sponsor_slug":"hunter-holmes-mcguire-veteran-affairs-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06095063","publication_url":"https://clinicaltrials.gov/study/NCT06095063","title":"Effect of Deep Transcranial Magnetic Stimulation (dTMS) on Cognition in Older Adults With Subjective Cognitive Decline (SCD)","has_exemption":false,"start_date":"2023-11-15","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Rotman Research Institute at Baycrest","sponsor_slug":"rotman-research-institute-at-baycrest","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05974488","publication_url":"https://clinicaltrials.gov/study/NCT05974488","title":"The Efficacy of Distal Pharyngeal Airway in Enhancing Oxygenation During Transesophageal Echocardiography (TEE) in Patients Sedated With Propofol","has_exemption":false,"start_date":"2023-11-30","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05999812","publication_url":"https://clinicaltrials.gov/study/NCT05999812","title":"Phase II Single-arm, Single-center Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Refractory Microsatellite Stable Colorectal Cancer","has_exemption":false,"start_date":"2023-12-19","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05564403","publication_url":"https://clinicaltrials.gov/study/NCT05564403","title":"FOLFOX in Combination With Binimetinib as 2nd Line Therapy for Patients With Advanced Biliary Tract Cancers With MAPK Pathway Alterations: A ComboMATCH Treatment Trial","has_exemption":false,"start_date":"2024-02-09","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05783323","publication_url":"https://clinicaltrials.gov/study/NCT05783323","title":"Larotrectinib to Enhance RAI Avidity in Patients With Differentiated Thyroid Cancer Harboring NTRK Fusions (LANTERN)","has_exemption":false,"start_date":"2024-02-14","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06200207","publication_url":"https://clinicaltrials.gov/study/NCT06200207","title":"Effects of Ziltivekimab Versus Placebo on Heart Failure Symptoms and Physical Function in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation","has_exemption":false,"start_date":"2024-04-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06724146","publication_url":"https://clinicaltrials.gov/study/NCT06724146","title":"Safety and Efficacy of Upper Arm Combined Treatment Sofwave and Pure Impact to Strength and Tone Muscles and Improve Lax Skin Appearance","has_exemption":false,"start_date":"2024-08-05","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Sofwave Medical LTD","sponsor_slug":"sofwave-medical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06284564","publication_url":"https://clinicaltrials.gov/study/NCT06284564","title":"A Phase II Study Bolstering Outcomes by Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma (BOOST-RCC)","has_exemption":false,"start_date":"2024-08-07","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06551402","publication_url":"https://clinicaltrials.gov/study/NCT06551402","title":"Dabigatran Versus Rivaroxaban in Cerebral Venous Thrombosis, a Randomized Controlled Trial","has_exemption":false,"start_date":"2024-08-09","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Kafrelsheikh University","sponsor_slug":"kafrelsheikh-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06278987","publication_url":"https://clinicaltrials.gov/study/NCT06278987","title":"Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture","has_exemption":false,"start_date":"2024-10-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06530524","publication_url":"https://clinicaltrials.gov/study/NCT06530524","title":"Pretherapy Botulinum Toxin to Reduce Radiation-related Xerostomia in Head and Neck Cancer","has_exemption":false,"start_date":"2024-10-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Sir Mortimer B. Davis - Jewish General Hospital","sponsor_slug":"sir-mortimer-b-davis-jewish-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06570590","publication_url":"https://clinicaltrials.gov/study/NCT06570590","title":"A Prospective Study of the Minimally Invasive Lapidus Procedure for Hallux Valgus Deformities Randomized With Arthroscopy or No Arthroscopy at St. Paul's Hospital in Vancouver, Canada","has_exemption":false,"start_date":"2024-10-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"St. Paul's Hospital, Canada","sponsor_slug":"st-pauls-hospital-canada","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05947955","publication_url":"https://clinicaltrials.gov/study/NCT05947955","title":"A Phase 2 Randomized Double-blind Placebo-controlled Study To Evaluate The Efficacy And Safety Of Adjunctive Recombinant Human Plasma Gelsolin With Standard Care For Moderate-to-Severe ARDS Due To Pneumonia Or Other Infections","has_exemption":false,"start_date":"2024-10-03","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"BioAegis Therapeutics Inc.","sponsor_slug":"bioaegis-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06427226","publication_url":"https://clinicaltrials.gov/study/NCT06427226","title":"Clinical Study to Evaluate the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients","has_exemption":false,"start_date":"2024-10-31","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Tanta University","sponsor_slug":"tanta-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06374147","publication_url":"https://clinicaltrials.gov/study/NCT06374147","title":"\"Prapela® SVS Incubator Pad: a Cost-effective Stochastic Vibrotactile Device to Improve the Clinical Course of Infants with Apnea of Prematurity.\"","has_exemption":false,"start_date":"2025-02-06","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Tufts Medical Center","sponsor_slug":"tufts-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06811272","publication_url":"https://clinicaltrials.gov/study/NCT06811272","title":"A Phase 2 Study of Outpatient Epcoritamab as Second Line Therapy in Non-Transplant Eligible Relapsed/Refractory Large B-cell Lymphoma","has_exemption":false,"start_date":"2025-06-05","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06409819","publication_url":"https://clinicaltrials.gov/study/NCT06409819","title":"Phase 1/ 2 Trial of Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients","has_exemption":false,"start_date":"2025-06-15","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07044362","publication_url":"https://clinicaltrials.gov/study/NCT07044362","title":"Histotripsy Plus Chemotherapy for Advanced Colorectal Liver Metastasis: A Prospective, Single-Armed Trial","has_exemption":false,"start_date":"2025-06-30","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Case Comprehensive Cancer Center","sponsor_slug":"case-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05639972","publication_url":"https://clinicaltrials.gov/study/NCT05639972","title":"A Feasibility Study of E7 TCR-T Cell Induction Therapy for Locoregionally Advanced HPV-Associated Cancers","has_exemption":false,"start_date":"2025-08-11","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Christian Hinrichs","sponsor_slug":"christian-hinrichs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06479824","publication_url":"https://clinicaltrials.gov/study/NCT06479824","title":"NHLBI and Cook Trans-Atrial Intra-Pericardial Tricuspid Annuloplasty (TRAIPTA) Early Feasibility Study","has_exemption":false,"start_date":"2025-08-19","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","sponsor_slug":"national-heart-lung-and-blood-institute-nhlbi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06742307","publication_url":"https://clinicaltrials.gov/study/NCT06742307","title":"Faricimab Fixed Quarterly Maintenance for Neovascular Age Related Macular Degeneration: A Prospective Case Series","has_exemption":false,"start_date":"2025-08-21","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Hospital Authority, Hong Kong","sponsor_slug":"hospital-authority-hong-kong","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217223","publication_url":"https://clinicaltrials.gov/study/NCT07217223","title":"Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study","has_exemption":false,"start_date":"2025-09-27","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07197203","publication_url":"https://clinicaltrials.gov/study/NCT07197203","title":"Comparison of Caudal Block and Sacral Erector Spinae Plane Block With Dexmedetomidine in Pediatric Penile Hypospadias Repair","has_exemption":false,"start_date":"2025-10-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07177326","publication_url":"https://clinicaltrials.gov/study/NCT07177326","title":"Combination Therapy of Tadalafil 2.5mg Plus Sildenafil 25mg Versus Tadalafil 5 mg Monotherapy for Treatment of Erectile Dysfunction: A Randomized, Placebo-Controlled Double-Blinded Cross-Over Study","has_exemption":false,"start_date":"2025-10-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07119268","publication_url":"https://clinicaltrials.gov/study/NCT07119268","title":"SPARK-Healthy Sleep: A Digital Health Intervention to Promote Behavioral, Emotional, and Cognitive Changes","has_exemption":false,"start_date":"2025-10-24","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07168525","publication_url":"https://clinicaltrials.gov/study/NCT07168525","title":"Effects of Ultrasound on Healthy Aging","has_exemption":false,"start_date":"2025-10-29","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07325188","publication_url":"https://clinicaltrials.gov/study/NCT07325188","title":"Clinical Evaluation of a Novel Intraoperative Guidance System for Accurate Toric IOL Positioning in Cataract Surgery","has_exemption":false,"start_date":"2025-11-04","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Gainesville Eye Associates","sponsor_slug":"gainesville-eye-associates","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07184983","publication_url":"https://clinicaltrials.gov/study/NCT07184983","title":"Telehealth-Delivered tDCS for Cannabis Addiction Recovery: The C.A.R.E.S. (Cannabis Addiction Recovery Enhancement Stimulation) Initiative","has_exemption":false,"start_date":"2025-11-12","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07123090","publication_url":"https://clinicaltrials.gov/study/NCT07123090","title":"A Phase 2 Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma - SPARCC","has_exemption":false,"start_date":"2025-11-24","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Stephanie Berg","sponsor_slug":"stephanie-berg","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06590454","publication_url":"https://clinicaltrials.gov/study/NCT06590454","title":"Therapeutic Intervention to Reverse Gastric Precancer","has_exemption":false,"start_date":"2025-12-15","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Katherine Garman","sponsor_slug":"katherine-garman","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07011147","publication_url":"https://clinicaltrials.gov/study/NCT07011147","title":"Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery","has_exemption":false,"start_date":"2026-01-16","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07040397","publication_url":"https://clinicaltrials.gov/study/NCT07040397","title":"Comparing an Electronic Approach to the Human Massage Therapist.","has_exemption":false,"start_date":"2026-02-28","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07198139","publication_url":"https://clinicaltrials.gov/study/NCT07198139","title":"A Phase 1b, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Norovirus","has_exemption":false,"start_date":"2026-03-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Cocrystal Pharma, Inc.","sponsor_slug":"cocrystal-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07335861","publication_url":"https://clinicaltrials.gov/study/NCT07335861","title":"Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers: A Randomized Controlled Multicenter Crossover Trial","has_exemption":false,"start_date":"2026-03-15","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"NuScience Medical Biologics, LLC","sponsor_slug":"nuscience-medical-biologics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07496463","publication_url":"https://clinicaltrials.gov/study/NCT07496463","title":"Setmelanotide to Treat Obesity in a Patient With Pseudohypoparathyroidism Type 1a (PHP1a)","has_exemption":false,"start_date":"2026-04-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07512206","publication_url":"https://clinicaltrials.gov/study/NCT07512206","title":"AERO CAD: A Prospective, Multi-Center, Single-Arm Study Evaluating the Shockwave C2 Aero Coronary IVL System in Calcified Coronary Artery Disease","has_exemption":false,"start_date":"2026-04-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"OPCI Core Laboratories LLC","sponsor_slug":"opci-core-laboratories-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07532876","publication_url":"https://clinicaltrials.gov/study/NCT07532876","title":"Comparison of Efficacy and Safety of Elagolix and OCPs in Reducing Endometriosis Associated Pelvic Pain","has_exemption":false,"start_date":"2026-05-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Pak Emirates Military Hospital","sponsor_slug":"pak-emirates-military-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04561206","publication_url":"https://clinicaltrials.gov/study/NCT04561206","title":"A Phase 2 Study of Brentuximab Vedotin Plus Nivolumab Without Stem Cell Consolidation in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma","has_exemption":false,"start_date":"2021-11-12","completion_date":"2026-10-02","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07363720","publication_url":"https://clinicaltrials.gov/study/NCT07363720","title":"A Double-blind, Placebo-Controlled, Randomized Withdrawal Trial to Evaluate the Efficacy and Safety of TAK-861 for the Treatment of Narcolepsy With Cataplexy (Narcolepsy Type 1)","has_exemption":false,"start_date":"2026-01-29","completion_date":"2026-10-02","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03869372","publication_url":"https://clinicaltrials.gov/study/NCT03869372","title":"Cerebral Cortical Influences on Autonomic Function","has_exemption":false,"start_date":"2019-04-05","completion_date":"2026-10-03","has_results":false,"results_due":false,"sponsor_name":"David Levinthal","sponsor_slug":"david-levinthal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05164094","publication_url":"https://clinicaltrials.gov/study/NCT05164094","title":"A Phase 1/2, Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults","has_exemption":false,"start_date":"2021-12-28","completion_date":"2026-10-05","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05268003","publication_url":"https://clinicaltrials.gov/study/NCT05268003","title":"A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia","has_exemption":false,"start_date":"2022-06-07","completion_date":"2026-10-05","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05511363","publication_url":"https://clinicaltrials.gov/study/NCT05511363","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Relapse Prevention Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease","has_exemption":false,"start_date":"2022-08-23","completion_date":"2026-10-05","has_results":false,"results_due":false,"sponsor_name":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","sponsor_slug":"karuna-therapeutics-inc-a-bristol-myers-squibb-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06863961","publication_url":"https://clinicaltrials.gov/study/NCT06863961","title":"A Phase II, Multicenter, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of RO7790121 in Patients With Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2025-04-01","completion_date":"2026-10-05","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05574101","publication_url":"https://clinicaltrials.gov/study/NCT05574101","title":"A Phase II, Multicenter, Single-Arm Clinical Trial of Radiotherapy and CeMiPlimAb: Rwlc ImmunoTherapy for Locally Advanced, Unresectable Cutaneous Squamous Cell Carcinoma: RAMPART","has_exemption":false,"start_date":"2022-10-06","completion_date":"2026-10-06","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06003426","publication_url":"https://clinicaltrials.gov/study/NCT06003426","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis","has_exemption":false,"start_date":"2023-09-14","completion_date":"2026-10-06","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04568837","publication_url":"https://clinicaltrials.gov/study/NCT04568837","title":"Postoperative Steroids and Recovery After Spine Fusion","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-10-06","has_results":false,"results_due":false,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07298382","publication_url":"https://clinicaltrials.gov/study/NCT07298382","title":"See the Impact Beem's Blue Light Therapy Has on Your Skin Health!","has_exemption":false,"start_date":"2025-10-06","completion_date":"2026-10-06","has_results":false,"results_due":false,"sponsor_name":"Efforia, Inc","sponsor_slug":"efforia-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02612454","publication_url":"https://clinicaltrials.gov/study/NCT02612454","title":"An Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Dupilumab in Patients ≥6 Months to <18 Years of Age With Atopic Dermatitis","has_exemption":false,"start_date":"2015-10-15","completion_date":"2026-10-07","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT07215104","publication_url":"https://clinicaltrials.gov/study/NCT07215104","title":"A Prospective Evaluation of Spinal Cord Induced Muscle Stimulation (MuscleSCS) for the Treatment of Chronic Low Back Pain","has_exemption":false,"start_date":"2025-10-07","completion_date":"2026-10-07","has_results":false,"results_due":false,"sponsor_name":"Saint Francis Hospital","sponsor_slug":"saint-francis-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05090358","publication_url":"https://clinicaltrials.gov/study/NCT05090358","title":"Targeting Insulin Feedback to Enhance Alpelisib (TIFA): A Phase 2 Randomized Control Trial in Metastatic PIK3CA-mutant Hormone-Receptor Positive Breast Cancer","has_exemption":false,"start_date":"2021-10-08","completion_date":"2026-10-08","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06332040","publication_url":"https://clinicaltrials.gov/study/NCT06332040","title":"A Randomized Controlled Trial to Evaluate the Effectiveness of Gentamicin Bladder Instillation on CAUTI","has_exemption":false,"start_date":"2023-10-09","completion_date":"2026-10-08","has_results":false,"results_due":false,"sponsor_name":"St. Joseph's Hospital and Medical Center, Phoenix","sponsor_slug":"st-josephs-hospital-and-medical-center-phoenix","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06616194","publication_url":"https://clinicaltrials.gov/study/NCT06616194","title":"AN INTERVENTIONAL, EFFICACY, AND SAFETY, PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AN OPEN-LABEL EXTENSION TO INVESTIGATE RIMEGEPANT IN MIGRAINE PREVENTION IN ADOLESCENTS 12 TO LESS THAN 18 YEARS OF AGE WITH CHRONIC MIGRAINE","has_exemption":false,"start_date":"2024-11-15","completion_date":"2026-10-08","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05202782","publication_url":"https://clinicaltrials.gov/study/NCT05202782","title":"Phase II, Single-Arm, Open-label, Multicenter Study Evaluating the Efficacy of Adjunctive Zanubrutinib and CAR T-Cell Therapy in Aggressive B-Cell Non-Hodgkin's Lymphoma","has_exemption":false,"start_date":"2022-03-21","completion_date":"2026-10-09","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06616974","publication_url":"https://clinicaltrials.gov/study/NCT06616974","title":"A Phase 2, Double-blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of TX000045 After 24 Weeks of Treatment in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (PH-HFpEF)","has_exemption":false,"start_date":"2024-09-04","completion_date":"2026-10-09","has_results":false,"results_due":false,"sponsor_name":"Tectonic Therapeutic","sponsor_slug":"tectonic-therapeutic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06958211","publication_url":"https://clinicaltrials.gov/study/NCT06958211","title":"A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa","has_exemption":false,"start_date":"2025-06-12","completion_date":"2026-10-09","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06959225","publication_url":"https://clinicaltrials.gov/study/NCT06959225","title":"A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa","has_exemption":false,"start_date":"2025-06-23","completion_date":"2026-10-09","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05367245","publication_url":"https://clinicaltrials.gov/study/NCT05367245","title":"Microbiome Targeted Oral Butyrate Therapy in Gulf War Multisymptom Illness","has_exemption":false,"start_date":"2024-01-15","completion_date":"2026-10-10","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06976697","publication_url":"https://clinicaltrials.gov/study/NCT06976697","title":"Safety And Efficacy of Remotely Supervised Home-Based tDCS Treatment Of Major Depressive Disorder","has_exemption":false,"start_date":"2025-06-27","completion_date":"2026-10-10","has_results":false,"results_due":false,"sponsor_name":"Sooma Medical Inc","sponsor_slug":"sooma-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07193459","publication_url":"https://clinicaltrials.gov/study/NCT07193459","title":"A Phase 3, Randomized, Double-blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of HDM1002 Tablets in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise Only","has_exemption":false,"start_date":"2025-08-12","completion_date":"2026-10-10","has_results":false,"results_due":false,"sponsor_name":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","sponsor_slug":"hangzhou-zhongmei-huadong-pharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07092137","publication_url":"https://clinicaltrials.gov/study/NCT07092137","title":"Nano-crystalline Megestrol Acetate for Anorexia-Cachexia in Advanced Lung Cancer: A Randomized, Double-Blind, Multicenter Study","has_exemption":false,"start_date":"2025-10-10","completion_date":"2026-10-10","has_results":false,"results_due":false,"sponsor_name":"Guangzhou Institute of Respiratory Disease","sponsor_slug":"guangzhou-institute-of-respiratory-disease","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07293611","publication_url":"https://clinicaltrials.gov/study/NCT07293611","title":"Prospective, Multicenter, Single-arm, Open-label Study to Assess the Safety and Feasibility of the Levita Magnetic Surgical System for Reduced Port in Upper Gastrointestinal Laparoscopic Procedures","has_exemption":false,"start_date":"2026-03-23","completion_date":"2026-10-10","has_results":false,"results_due":false,"sponsor_name":"Levita Magnetics","sponsor_slug":"levita-magnetics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03821792","publication_url":"https://clinicaltrials.gov/study/NCT03821792","title":"A Phase 2 Course Determining Study for Men With Hormone-Naïve Metastatic Prostate Cancer (HNMPCa)","has_exemption":false,"start_date":"2019-07-22","completion_date":"2026-10-11","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05696184","publication_url":"https://clinicaltrials.gov/study/NCT05696184","title":"Pathophysiology of Pharyngo-esophageal Junction and Esophageal Mechanisms Preventing Pharyngeal Reflux of Gastric Content","has_exemption":false,"start_date":"2013-11-01","completion_date":"2026-10-12","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05372354","publication_url":"https://clinicaltrials.gov/study/NCT05372354","title":"An Exploratory Phase 1b/2a Multicenter, Open-Label, Novel-Novel Combination Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of CC-92480 (BMS-986348) in Novel Therapeutic Combinations in Participants With Relapsed or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2022-10-18","completion_date":"2026-10-12","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05884398","publication_url":"https://clinicaltrials.gov/study/NCT05884398","title":"A Phase 3, Open-label, Randomized, Prospective Study of Apalutamide With Continued Versus Intermittent Androgen-Deprivation Therapy (ADT) Following PSA Response in Participants With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)","has_exemption":false,"start_date":"2023-08-31","completion_date":"2026-10-12","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07523412","publication_url":"https://clinicaltrials.gov/study/NCT07523412","title":"Dimensional Changes of Peri-implant Tissues Following Jumping Gap Grafting Using Erythropoietin Gel Mixed With Xenograft. (A Randomized Controlled Clinical Study)","has_exemption":false,"start_date":"2026-04-12","completion_date":"2026-10-12","has_results":false,"results_due":false,"sponsor_name":"Ain Shams University","sponsor_slug":"ain-shams-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04998396","publication_url":"https://clinicaltrials.gov/study/NCT04998396","title":"A Phase 1/2 Open-Label Study of the Safety and Clinical Activity of Gene Therapy for Canavan Disease Through Administration of an Adeno-Associated Virus (AAV) Serotype 9-Based Recombinant Vector Encoding the Human ASPA Gene","has_exemption":false,"start_date":"2021-09-08","completion_date":"2026-10-13","has_results":false,"results_due":false,"sponsor_name":"Aspa Therapeutics","sponsor_slug":"aspa-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05389215","publication_url":"https://clinicaltrials.gov/study/NCT05389215","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of DWN12088 in Patients With Idiopathic Pulmonary Fibrosis","has_exemption":false,"start_date":"2022-07-29","completion_date":"2026-10-13","has_results":false,"results_due":false,"sponsor_name":"Daewoong Pharmaceutical Co. LTD.","sponsor_slug":"daewoong-pharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06521567","publication_url":"https://clinicaltrials.gov/study/NCT06521567","title":"Phase 1/2 Dose Determination and Dose Expansion Study of Cobolimab in Combination With Dostarlimab in Pediatric and Young Adult Participants With Newly Diagnosed and Relapsed/Refractory Tumors (POPSTAR)","has_exemption":false,"start_date":"2025-03-06","completion_date":"2026-10-13","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03707340","publication_url":"https://clinicaltrials.gov/study/NCT03707340","title":"A Feasibility Study of Flibanserin in Breast Cancer Survivors on Tamoxifen and Aromatase Inhibitors","has_exemption":false,"start_date":"2018-09-14","completion_date":"2026-10-14","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06517875","publication_url":"https://clinicaltrials.gov/study/NCT06517875","title":"A Phase 2 Open-label Study to Evaluate Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Primary or Secondary Myelofibrosis","has_exemption":false,"start_date":"2025-02-28","completion_date":"2026-10-14","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06847724","publication_url":"https://clinicaltrials.gov/study/NCT06847724","title":"A Randomized, Double-blind, Parallel-group Study to Compare the Pharmacokinetics, Efficacy, Pharmacodynamics, Safety, and Immunogenicity of CYB704 (Proposed Ocrelizumab Biosimilar) and Ocrevus® in Participants With Relapsing Multiple Sclerosis (RMS) [STRIVE-MS].","has_exemption":false,"start_date":"2025-06-10","completion_date":"2026-10-14","has_results":false,"results_due":false,"sponsor_name":"Sandoz","sponsor_slug":"sandoz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03368742","publication_url":"https://clinicaltrials.gov/study/NCT03368742","title":"A Randomized, Controlled, Open-label, Single-ascending Dose, Phase I/II Study to Investigate the Safety and Tolerability, and Efficacy of Intravenous SGT-001 in Male Adolescents and Children With Duchenne Muscular Dystrophy","has_exemption":false,"start_date":"2017-12-06","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"Solid Biosciences Inc.","sponsor_slug":"solid-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04144894","publication_url":"https://clinicaltrials.gov/study/NCT04144894","title":"The Biosonographic Index - A Novel Index for the Early Detection of Acute Kidney Injury After Vascular Surgery - an Exploratory Study.","has_exemption":false,"start_date":"2020-01-15","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04850599","publication_url":"https://clinicaltrials.gov/study/NCT04850599","title":"A Single-Arm Phase II Study of Isatuximab With Carfilzomib and Pomalidomide in Relapsed or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2022-06-14","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"OHSU Knight Cancer Institute","sponsor_slug":"ohsu-knight-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05605535","publication_url":"https://clinicaltrials.gov/study/NCT05605535","title":"A Phase 2, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial Comparing Chemoimmunotherapy (Paclitaxel-Carboplatin-Oregovomab) Versus Chemotherapy (Paclitaxel-Carboplatin-Placebo) as Neoadjuvant Therapy in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma","has_exemption":false,"start_date":"2023-02-07","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"CanariaBio Inc.","sponsor_slug":"canariabio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06720350","publication_url":"https://clinicaltrials.gov/study/NCT06720350","title":"Efficacy of Romosozumab and Denosumab Combined Treatment in Postmenopausal Osteoporosis Patients with Multiple Fragility Fractures","has_exemption":false,"start_date":"2025-01-15","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"Marmara University","sponsor_slug":"marmara-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06795048","publication_url":"https://clinicaltrials.gov/study/NCT06795048","title":"A Phase IIIb/IV, Multicenter, Randomized, Open-Label, Two-Arm Study to Investigate the Efficacy, Safety, and Durability of Faricimab Administered up to Every 24 Weeks in Patients With Neovascular Age-Related Macular Degeneration","has_exemption":false,"start_date":"2025-03-14","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07111494","publication_url":"https://clinicaltrials.gov/study/NCT07111494","title":"Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial","has_exemption":false,"start_date":"2025-10-15","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07497672","publication_url":"https://clinicaltrials.gov/study/NCT07497672","title":"Evaluation of Novel Spectacles Intended for Myopia Management in a Short-Term Study","has_exemption":false,"start_date":"2026-04-15","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"Myoptechs, Inc","sponsor_slug":"myoptechs-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03533283","publication_url":"https://clinicaltrials.gov/study/NCT03533283","title":"An Open-Label, Multi-Center, Phase IB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin (Plus a Single Pre-Treatment Dose of Obinutuzumab) in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma","has_exemption":false,"start_date":"2018-05-08","completion_date":"2026-10-16","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06028022","publication_url":"https://clinicaltrials.gov/study/NCT06028022","title":"Reishi Mushroom Extract for Fatigue and/or Arthralgias in Patients With Breast Cancer on Aromatase Inhibitors: A Randomized Phase II MNCCTN Trial","has_exemption":false,"start_date":"2023-10-18","completion_date":"2026-10-16","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05977907","publication_url":"https://clinicaltrials.gov/study/NCT05977907","title":"Neoadjuvant Pembrolizumab and IO102-103 Prior to Curative-intent Surgical Care for Squamous Cell Carcinoma of the Head and Neck (SCCHN)","has_exemption":false,"start_date":"2023-12-14","completion_date":"2026-10-16","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06054776","publication_url":"https://clinicaltrials.gov/study/NCT06054776","title":"A Phase 2 Study of Glofitamab With Acalabrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma","has_exemption":false,"start_date":"2024-12-02","completion_date":"2026-10-16","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06722157","publication_url":"https://clinicaltrials.gov/study/NCT06722157","title":"Randomized, Double-masked, Active-controlled, Multicenter Study to Evaluate Efficacy and Safety of Two Regimens of Intravitreal BI 771716 Against Pegcetacoplan in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration VERDANT Trial","has_exemption":false,"start_date":"2025-01-06","completion_date":"2026-10-16","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06671002","publication_url":"https://clinicaltrials.gov/study/NCT06671002","title":"Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids (CARES for Kids) Trial","has_exemption":false,"start_date":"2025-01-10","completion_date":"2026-10-16","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07288138","publication_url":"https://clinicaltrials.gov/study/NCT07288138","title":"A Phase 2a, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of a THRβ Agonist (ECC4703), an SSAO Inhibitor (ECC0509), and Their Combination in Adults With Presumed MASH","has_exemption":false,"start_date":"2025-12-15","completion_date":"2026-10-16","has_results":false,"results_due":false,"sponsor_name":"Eccogene","sponsor_slug":"eccogene","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07033585","publication_url":"https://clinicaltrials.gov/study/NCT07033585","title":"Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers","has_exemption":false,"start_date":"2025-06-15","completion_date":"2026-10-18","has_results":false,"results_due":false,"sponsor_name":"Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair","sponsor_slug":"han-xu-md-phd-fapcr-sponsor-investigator-irb-chair","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03953300","publication_url":"https://clinicaltrials.gov/study/NCT03953300","title":"A Phase 4, Multicenter, Randomized, Double-blind, Parallel Group, Placebo Controlled Study to Evaluate the Effect of Benralizumab on Structural and Lung Function Changes in Severe Eosinophilic Asthmatics","has_exemption":false,"start_date":"2019-10-08","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05100472","publication_url":"https://clinicaltrials.gov/study/NCT05100472","title":"Phase II Trial of Short Course Androgen Deprivation, Hypofractionated Pelvic Radiation and a Brachytherapy Boost for NCCN High-Risk Prostate Cancer With Low-Intermediate Risk Decipher Genomic Score","has_exemption":false,"start_date":"2021-10-19","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05617677","publication_url":"https://clinicaltrials.gov/study/NCT05617677","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-1)","has_exemption":false,"start_date":"2023-01-12","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05620407","publication_url":"https://clinicaltrials.gov/study/NCT05620407","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-2)","has_exemption":false,"start_date":"2023-01-12","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05995964","publication_url":"https://clinicaltrials.gov/study/NCT05995964","title":"A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF PF-07275315 AND PF-07264660 IN ADULT PARTICIPANTS WITH MODERATE-SEVERE ATOPIC DERMATITIS","has_exemption":false,"start_date":"2023-08-22","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06376045","publication_url":"https://clinicaltrials.gov/study/NCT06376045","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Asthma","has_exemption":false,"start_date":"2024-05-24","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06516952","publication_url":"https://clinicaltrials.gov/study/NCT06516952","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis","has_exemption":false,"start_date":"2024-10-10","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06516965","publication_url":"https://clinicaltrials.gov/study/NCT06516965","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis","has_exemption":false,"start_date":"2024-10-10","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06698822","publication_url":"https://clinicaltrials.gov/study/NCT06698822","title":"A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA","has_exemption":false,"start_date":"2025-03-10","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05531565","publication_url":"https://clinicaltrials.gov/study/NCT05531565","title":"A 2-Part Seamless Part A (Phase 2)/Part B (Phase 3) Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BIIB059 in Participants With Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST)","has_exemption":false,"start_date":"2022-09-13","completion_date":"2026-10-20","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06311682","publication_url":"https://clinicaltrials.gov/study/NCT06311682","title":"A Phase 3 Multi-center Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children (Age 2 to <12 Years) and Infants (Age 6 Months to <2 Years) With Moderate-to-severe Atopic Dermatitis. The Trial is Randomized, Double-blind, Placebo-controlled, and Parallel-group for Children (Age 2 to <12 Years) and Open-label and Single-group for Infants (Age 6 Months to <2 Years)","has_exemption":false,"start_date":"2024-06-10","completion_date":"2026-10-20","has_results":false,"results_due":false,"sponsor_name":"LEO Pharma","sponsor_slug":"leo-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06894212","publication_url":"https://clinicaltrials.gov/study/NCT06894212","title":"A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia","has_exemption":false,"start_date":"2025-02-28","completion_date":"2026-10-20","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","sponsor_slug":"otsuka-pharmaceutical-development-commercialization-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07122843","publication_url":"https://clinicaltrials.gov/study/NCT07122843","title":"Real Time Guided Meditations for Pain in Virtual Reality Study","has_exemption":false,"start_date":"2025-11-06","completion_date":"2026-10-20","has_results":false,"results_due":false,"sponsor_name":"Christopher Almario","sponsor_slug":"christopher-almario","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07477704","publication_url":"https://clinicaltrials.gov/study/NCT07477704","title":"A Randomized, Open-Label, Dose-Ranging Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Weekly Alirocumab in Adults With Hypercholesterolemia","has_exemption":false,"start_date":"2026-04-14","completion_date":"2026-10-20","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03587311","publication_url":"https://clinicaltrials.gov/study/NCT03587311","title":"A Randomized Phase 2 Study of Bevacizumab and Either Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant or Platinum Refractory Ovarian Cancer","has_exemption":false,"start_date":"2018-10-12","completion_date":"2026-10-21","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05208307","publication_url":"https://clinicaltrials.gov/study/NCT05208307","title":"Maintenance Therapy With Belantamab, Pomalidomide and Dexamethasone (BPd) in High-Risk Myeloma Patients: A Phase 2 Study With a Safety Run-In","has_exemption":false,"start_date":"2022-07-21","completion_date":"2026-10-21","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06668766","publication_url":"https://clinicaltrials.gov/study/NCT06668766","title":"Superior Ultrasound-Guided Venous Access: Single-Lumen Midline Catheters vs Long Peripheral IVs for Difficult IV Access in the Emergency Department, A Randomized Controlled Trial","has_exemption":false,"start_date":"2025-01-01","completion_date":"2026-10-21","has_results":false,"results_due":false,"sponsor_name":"Albany Medical College","sponsor_slug":"albany-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282275","publication_url":"https://clinicaltrials.gov/study/NCT07282275","title":"How Does Continued Use of Green Light Therapy Impact Outcomes?","has_exemption":false,"start_date":"2025-10-21","completion_date":"2026-10-21","has_results":false,"results_due":false,"sponsor_name":"Efforia, Inc","sponsor_slug":"efforia-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04992624","publication_url":"https://clinicaltrials.gov/study/NCT04992624","title":"Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee","has_exemption":false,"start_date":"2022-02-22","completion_date":"2026-10-22","has_results":false,"results_due":false,"sponsor_name":"Steven E Harte, PhD","sponsor_slug":"steven-e-harte-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06245408","publication_url":"https://clinicaltrials.gov/study/NCT06245408","title":"A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome With Moderate-to-Severe Symptom State (HZNP-DAZ-303)","has_exemption":false,"start_date":"2024-04-08","completion_date":"2026-10-22","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07403669","publication_url":"https://clinicaltrials.gov/study/NCT07403669","title":"Cardiovascular Kidney and Metaboolic (CKM) Health Assessment and Patient Empowerment in chROnic Disease Using a Health Coach INtervention ModEl: A Randomized Clinical Trial","has_exemption":false,"start_date":"2025-10-22","completion_date":"2026-10-22","has_results":false,"results_due":false,"sponsor_name":"Aventyn, Inc.","sponsor_slug":"aventyn-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05859334","publication_url":"https://clinicaltrials.gov/study/NCT05859334","title":"A Phase 2 Study of Erdafitinib in Patients With Recurrent or Progressive IDH-Wild Type Glioma With an FGFR-TACC Gene Fusion","has_exemption":false,"start_date":"2024-01-04","completion_date":"2026-10-23","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07230964","publication_url":"https://clinicaltrials.gov/study/NCT07230964","title":"Early Feasibility Study of the Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis","has_exemption":false,"start_date":"2025-11-10","completion_date":"2026-10-23","has_results":false,"results_due":false,"sponsor_name":"Dermed Diagnostics, Inc.","sponsor_slug":"dermed-diagnostics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07476339","publication_url":"https://clinicaltrials.gov/study/NCT07476339","title":"A Multi-Center, Single-Arm, Open-Label, Prospective, Phase 4 Study to Investigate the Safety and Efficacy of Rapidly Restarting Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Viremic and Virologically-Suppressed Male and Female HIV-Positive Patients Aged ≥18 Years Who Are Treatment-Experienced and Returning to Care After Experiencing a Treatment Interruption of ≥12 Weeks","has_exemption":false,"start_date":"2026-03-23","completion_date":"2026-10-23","has_results":false,"results_due":false,"sponsor_name":"CAN Community Health","sponsor_slug":"can-community-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221682","publication_url":"https://clinicaltrials.gov/study/NCT07221682","title":"Comparison For Ease Of Spinal Positioning & Duration Of Post-Op Analgesia Between Ultrasound Guided Supra-Inguinal Fascia Iliaca Block Vs Ultrasound Guided Infra-Inguinal Fascia Iliaca Block In Patients Undergoing Thigh & Knee Surgeries","has_exemption":false,"start_date":"2024-05-06","completion_date":"2026-10-25","has_results":false,"results_due":false,"sponsor_name":"Sahiwal medical college sahiwal","sponsor_slug":"sahiwal-medical-college-sahiwal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04204616","publication_url":"https://clinicaltrials.gov/study/NCT04204616","title":"A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects With Prurigo Nodularis","has_exemption":false,"start_date":"2021-01-11","completion_date":"2026-10-26","has_results":false,"results_due":false,"sponsor_name":"Galderma R&D","sponsor_slug":"galderma-rd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05360446","publication_url":"https://clinicaltrials.gov/study/NCT05360446","title":"A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase IIIb Study Evaluating the Effect of Inclisiran on Atherosclerotic Plaque Progression Assessed by Coronary Computed Tomography Angiography (CCTA) in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events (VICTORION-PLAQUE)","has_exemption":false,"start_date":"2022-07-08","completion_date":"2026-10-26","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05775159","publication_url":"https://clinicaltrials.gov/study/NCT05775159","title":"A Phase II, Open-Label, Multi-Drug, Multi-Center, Master Protocol to Evaluate the Efficacy and Safety of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer (GEMINI-Hepatobiliary)","has_exemption":false,"start_date":"2023-04-24","completion_date":"2026-10-27","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06789757","publication_url":"https://clinicaltrials.gov/study/NCT06789757","title":"An Open Label Phase II Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma","has_exemption":false,"start_date":"2025-02-25","completion_date":"2026-10-27","has_results":false,"results_due":false,"sponsor_name":"Inova Health Care Services","sponsor_slug":"inova-health-care-services","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05168930","publication_url":"https://clinicaltrials.gov/study/NCT05168930","title":"A Phase 2 Trial of Zanubrutinib and Venetoclax in Previously Treated CLL/SLL Patients","has_exemption":false,"start_date":"2022-02-18","completion_date":"2026-10-28","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05239728","publication_url":"https://clinicaltrials.gov/study/NCT05239728","title":"A Multicenter, Double-blind, Randomized Phase 3 Study to Compare the Efficacy and Safety of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in the Adjuvant Treatment of Clear Cell Renal Cell Carcinoma (ccRCC) Post Nephrectomy (MK-6482-022)","has_exemption":false,"start_date":"2022-03-15","completion_date":"2026-10-28","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06527404","publication_url":"https://clinicaltrials.gov/study/NCT06527404","title":"A Phase 3, 52-Week, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety, and Tolerability of Rocatinlimab in Adult Subjects With Prurigo Nodularis Who Are Inadequately Controlled on Topical Therapies or Not Eligible for Topical Therapies","has_exemption":false,"start_date":"2024-07-18","completion_date":"2026-10-28","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04736706","publication_url":"https://clinicaltrials.gov/study/NCT04736706","title":"An Open-label, Randomized Phase 3 Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or MK-1308A in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, as First-Line Treatment in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)","has_exemption":false,"start_date":"2021-04-14","completion_date":"2026-10-29","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05973773","publication_url":"https://clinicaltrials.gov/study/NCT05973773","title":"Randomized, Controlled, Open-label, Phase 3, Global Multi - Center Trial to Assess the Efficacy and Safety of Zipalertinib Plus Chemotherapy Versus Chemotherapy Alone, in Patients With Previously Untreated, Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations","has_exemption":false,"start_date":"2023-12-18","completion_date":"2026-10-29","has_results":false,"results_due":false,"sponsor_name":"Taiho Oncology, Inc.","sponsor_slug":"taiho-oncology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06260033","publication_url":"https://clinicaltrials.gov/study/NCT06260033","title":"A Phase II Trial of Stereotactic Body Radiation Therapy and Fluoroestradiol Positron Emission Tomography in Patients With Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer","has_exemption":false,"start_date":"2024-07-23","completion_date":"2026-10-29","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06668376","publication_url":"https://clinicaltrials.gov/study/NCT06668376","title":"A Study to Evaluate the Incrediwear Products Immediately After ACL or ACL+MCL Arthroscopic Surgery","has_exemption":false,"start_date":"2024-10-29","completion_date":"2026-10-29","has_results":false,"results_due":false,"sponsor_name":"Texas Bone and Joint","sponsor_slug":"texas-bone-and-joint","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02843035","publication_url":"https://clinicaltrials.gov/study/NCT02843035","title":"A 4-part, Open-label, Multicenter, Multinational Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamic, and Exploratory Efficacy of Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 With Venglustat Monotherapy Extension","has_exemption":false,"start_date":"2017-01-04","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Genzyme, a Sanofi Company","sponsor_slug":"genzyme-a-sanofi-company","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03452202","publication_url":"https://clinicaltrials.gov/study/NCT03452202","title":"Using tDCS in Speech-based Stroke Rehabilitation","has_exemption":false,"start_date":"2019-01-11","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04041310","publication_url":"https://clinicaltrials.gov/study/NCT04041310","title":"A Phase I/II, Multicenter, Open-Label Study of Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors","has_exemption":false,"start_date":"2019-10-21","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Nouscom SRL","sponsor_slug":"nouscom-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04198766","publication_url":"https://clinicaltrials.gov/study/NCT04198766","title":"An Open-Label, Multicenter, First-in-Human, Dose-Escalation, Multicohort, Phase 1/2 Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab in Subjects With Locally Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2019-12-10","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Inhibrx Biosciences, Inc","sponsor_slug":"inhibrx-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04565665","publication_url":"https://clinicaltrials.gov/study/NCT04565665","title":"Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia","has_exemption":false,"start_date":"2020-07-29","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04582279","publication_url":"https://clinicaltrials.gov/study/NCT04582279","title":"Application of Lung Ultrasound Artefact Analysis for Exclusion of Acute Rejection in Asymptomatic Lung Transplant Recipients","has_exemption":false,"start_date":"2020-10-28","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04675710","publication_url":"https://clinicaltrials.gov/study/NCT04675710","title":"Pembrolizumab in Combination With Dabrafenib and Trametinib as a Neoadjuvant Strategy Prior to Surgery in BRAF-Mutated Anaplastic Thyroid Cancer","has_exemption":false,"start_date":"2021-06-24","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04793412","publication_url":"https://clinicaltrials.gov/study/NCT04793412","title":"Cochlear Implantation in Children With Asymmetric Hearing Loss or Single-Sided Deafness Clinical Trial","has_exemption":false,"start_date":"2021-09-20","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05007873","publication_url":"https://clinicaltrials.gov/study/NCT05007873","title":"Phase II Study Assessing Safety and Clinical Activity of the Combination of ASTX727 With Dasatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP)","has_exemption":false,"start_date":"2021-10-21","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04851613","publication_url":"https://clinicaltrials.gov/study/NCT04851613","title":"A Phase Ib/III Study to Evaluate the Efficacy and Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer Who Failed Standard of Care Therapies","has_exemption":false,"start_date":"2022-02-18","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Laekna Limited","sponsor_slug":"laekna-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05444257","publication_url":"https://clinicaltrials.gov/study/NCT05444257","title":"A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121/TEZ/D-IVA Combination Therapy in Subjects With Cystic Fibrosis","has_exemption":false,"start_date":"2022-11-08","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05340465","publication_url":"https://clinicaltrials.gov/study/NCT05340465","title":"Trial of Darbepoetin Plus Slow-release Intravenous Iron to Decrease Transfusions and Improve Iron Status and Neurodevelopment in Preterm Infants","has_exemption":false,"start_date":"2022-11-27","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05293600","publication_url":"https://clinicaltrials.gov/study/NCT05293600","title":"Treating Residual OSA With Endotype-directed Pharmacotherapy (Aim 3)","has_exemption":false,"start_date":"2023-07-01","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05972018","publication_url":"https://clinicaltrials.gov/study/NCT05972018","title":"Liposomal Bupivacaine/Bupivacaine A Single-Dose Bilateral Rectus Sheath Blocks Versus Ropivacaine in Bilateral Rectus Sheath Blocks And Catheters With Intermittent Hourly Boluses.","has_exemption":false,"start_date":"2023-10-18","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Hartford Hospital","sponsor_slug":"hartford-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06385925","publication_url":"https://clinicaltrials.gov/study/NCT06385925","title":"Phase 1/2 Study of TSN1611 in Subjects With Advanced Solid Tumors Harboring KRAS G12D Mutation","has_exemption":false,"start_date":"2024-04-29","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Tyligand Pharmaceuticals (Suzhou) Limited","sponsor_slug":"tyligand-pharmaceuticals-suzhou-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06218706","publication_url":"https://clinicaltrials.gov/study/NCT06218706","title":"A Randomized, Sham-Controlled Trial Investigating Low Intensity Focused Ultrasound as a Novel Treatment for Refractory Opioid Use Disorder","has_exemption":false,"start_date":"2024-05-09","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Ali Rezai","sponsor_slug":"ali-rezai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06233799","publication_url":"https://clinicaltrials.gov/study/NCT06233799","title":"Randomized, Placebo-Controlled, Multi-Site Trial of Extended-Release Naltrexone Injection/Bupropion XL Tablets in the Treatment of Methamphetamine Use Disorder","has_exemption":false,"start_date":"2024-07-01","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"National Institute on Drug Abuse (NIDA)","sponsor_slug":"national-institute-on-drug-abuse-nida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06143306","publication_url":"https://clinicaltrials.gov/study/NCT06143306","title":"Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement","has_exemption":false,"start_date":"2024-08-14","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06641765","publication_url":"https://clinicaltrials.gov/study/NCT06641765","title":"Continuous Glucose Monitoring in Haemodialysis and Peritoneal Dialysis Patients With Type 1 and Type 2 Diabetes","has_exemption":false,"start_date":"2024-11-01","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Bo Feldt-Rasmussen","sponsor_slug":"bo-feldt-rasmussen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06923891","publication_url":"https://clinicaltrials.gov/study/NCT06923891","title":"An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia Patients","has_exemption":false,"start_date":"2025-04-16","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Vanguard Research Group","sponsor_slug":"vanguard-research-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06985342","publication_url":"https://clinicaltrials.gov/study/NCT06985342","title":"A Prospective, Open-Label Study Examining the Use of Rimegepant ODT 75 mg or Zavegepant Nasal Spray 10 mg for Acute Treatment of Migraine in the Emergency Department Setting","has_exemption":false,"start_date":"2025-06-05","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07240831","publication_url":"https://clinicaltrials.gov/study/NCT07240831","title":"Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring","has_exemption":false,"start_date":"2025-12-15","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Biobeat Technologies Ltd.","sponsor_slug":"biobeat-technologies-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07005050","publication_url":"https://clinicaltrials.gov/study/NCT07005050","title":"Renal Pelvic Denervation Pilot Trial","has_exemption":false,"start_date":"2025-12-30","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Verve Medical, Inc","sponsor_slug":"verve-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07312006","publication_url":"https://clinicaltrials.gov/study/NCT07312006","title":"Comparison of AirSeal to DV5 Insufflation in Gastric Sleeve Procedures - The \"CAT5-GS\" Study","has_exemption":false,"start_date":"2026-01-30","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"SurgiQuest, Inc.","sponsor_slug":"surgiquest-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06965621","publication_url":"https://clinicaltrials.gov/study/NCT06965621","title":"An Open-Label, Exploratory, Phase 2 Scintigraphy Study Evaluating 18F mFBG for Imaging Myocardial Sympathetic Innervation in Subjects With Heart Failure and Implantable Cardioverter-Defibrillators","has_exemption":false,"start_date":"2026-04-28","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)","sponsor_slug":"innervate-radiopharmaceuticals-llc-formerly-illumina-radiopharmaceuticals-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07400666","publication_url":"https://clinicaltrials.gov/study/NCT07400666","title":"Intra-gastrointestinal Monitoring Device (PressureDOT®) and Centurion Intra-abdominal Pressure Monitoring Device Comparison Study: Pivotal Study of Safety and Performance.","has_exemption":false,"start_date":"2026-07-01","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Dotspace Inc.","sponsor_slug":"dotspace-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07490496","publication_url":"https://clinicaltrials.gov/study/NCT07490496","title":"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of CPL-01 in the Management of Postoperative Pain After Unilateral Distal First Metatarsal Bunionectomy With Osteotomy","has_exemption":false,"start_date":"2026-07-01","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Cali Pharmaceuticals LLC","sponsor_slug":"cali-pharmaceuticals-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00508443","publication_url":"https://clinicaltrials.gov/study/NCT00508443","title":"Phase I/II Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS) for the Treatment of Metastatic Spine Disease","has_exemption":false,"start_date":"2002-10-25","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00077285","publication_url":"https://clinicaltrials.gov/study/NCT00077285","title":"A Pilot Phase II Trial Of Irinotecan Plus Carboplatin, And Irinotecan Maintenance Therapy (High-Risk Patients Only), Integrated Into The Upfront Therapy Of Newly Diagnosed Patients With Intermediate - And High-Risk Rhabdomyosarcoma","has_exemption":false,"start_date":"2003-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00501826","publication_url":"https://clinicaltrials.gov/study/NCT00501826","title":"Phase II Study of Hyper-CVAD Plus Nelarabine in Previously Untreated T-ALL and Lymphoblastic Lymphoma","has_exemption":false,"start_date":"2007-07-11","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00869232","publication_url":"https://clinicaltrials.gov/study/NCT00869232","title":"UARK 2008-02, A Phase II Trial for High-risk Myeloma Evaluation Accelerating and Sustaining Complete Remission (AS-CR) by Applying Non-host-exhausting and Timely Dose-reduced MEL-80-VRD-PACE Tandem Transplants","has_exemption":false,"start_date":"2008-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Arkansas","sponsor_slug":"university-of-arkansas","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01189786","publication_url":"https://clinicaltrials.gov/study/NCT01189786","title":"Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection (EXCESS)","has_exemption":false,"start_date":"2010-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01223248","publication_url":"https://clinicaltrials.gov/study/NCT01223248","title":"A Phase III Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy in Patients With Metastatic Cancer","has_exemption":false,"start_date":"2010-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01269853","publication_url":"https://clinicaltrials.gov/study/NCT01269853","title":"Phase I/II Trial Of Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab (Avastin) for Treatment of Relapsed/Refractory Glioblastoma Multiforme and Anaplastic Astrocytoma.","has_exemption":false,"start_date":"2010-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01220583","publication_url":"https://clinicaltrials.gov/study/NCT01220583","title":"A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors","has_exemption":false,"start_date":"2011-01-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Radiation Therapy Oncology Group","sponsor_slug":"radiation-therapy-oncology-group","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02178410","publication_url":"https://clinicaltrials.gov/study/NCT02178410","title":"Vitamin D and Omega-3 Trial (VITAL Rhythm Study)","has_exemption":false,"start_date":"2012-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01881503","publication_url":"https://clinicaltrials.gov/study/NCT01881503","title":"Expanded Access Protocol for the Treatment Use of HBOC-201","has_exemption":false,"start_date":"2013-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Englewood Hospital and Medical Center","sponsor_slug":"englewood-hospital-and-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02015013","publication_url":"https://clinicaltrials.gov/study/NCT02015013","title":"Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models","has_exemption":false,"start_date":"2014-01-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02269150","publication_url":"https://clinicaltrials.gov/study/NCT02269150","title":"A Randomized Controlled Trial of Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation","has_exemption":false,"start_date":"2014-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02323867","publication_url":"https://clinicaltrials.gov/study/NCT02323867","title":"UNRELATED AND PARTIALLY MATCHED RELATED DONOR PERIPHERAL STEM CELL TRANSPLANTATION WITH Alpha/Beta T CELL AND B CELL DEPLETION FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES","has_exemption":false,"start_date":"2014-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02488967","publication_url":"https://clinicaltrials.gov/study/NCT02488967","title":"A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer","has_exemption":false,"start_date":"2015-07-26","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"NRG Oncology","sponsor_slug":"nrg-oncology","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03119584","publication_url":"https://clinicaltrials.gov/study/NCT03119584","title":"Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial","has_exemption":false,"start_date":"2015-09-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Texas Tech University Health Sciences Center, El Paso","sponsor_slug":"texas-tech-university-health-sciences-center-el-paso","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02570542","publication_url":"https://clinicaltrials.gov/study/NCT02570542","title":"A Multi-center Randomized Phase II Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)","has_exemption":false,"start_date":"2015-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02725060","publication_url":"https://clinicaltrials.gov/study/NCT02725060","title":"Autoimmune Basis for Postural Tachycardia Syndrome","has_exemption":false,"start_date":"2016-02-29","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02716116","publication_url":"https://clinicaltrials.gov/study/NCT02716116","title":"A Phase 1/2 Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of the Oral EGFR/HER2 Inhibitor TAK-788 (AP32788) in Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2016-06-16","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02923570","publication_url":"https://clinicaltrials.gov/study/NCT02923570","title":"A Phase II Randomized Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Unilateral Head and Neck Cancer","has_exemption":false,"start_date":"2016-10-03","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02932280","publication_url":"https://clinicaltrials.gov/study/NCT02932280","title":"A Phase I/II Study of Neratinib in Pediatric Patients With Relapsed or Refractory Solid Tumors","has_exemption":false,"start_date":"2016-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02921022","publication_url":"https://clinicaltrials.gov/study/NCT02921022","title":"Pilot Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2016-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03141684","publication_url":"https://clinicaltrials.gov/study/NCT03141684","title":"A Phase 2 Study of Anti-PD-L1 Antibody (Atezolizumab) in Alveolar Soft Part Sarcoma","has_exemption":false,"start_date":"2017-04-25","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03122717","publication_url":"https://clinicaltrials.gov/study/NCT03122717","title":"A Phase 1/2 Study of Osimertinib in Combination With Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer","has_exemption":false,"start_date":"2017-05-09","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03168659","publication_url":"https://clinicaltrials.gov/study/NCT03168659","title":"Post-Approval Study of the HeartLight Endoscopic Ablation System for the Treatment of Atrial Fibrillation","has_exemption":false,"start_date":"2017-06-16","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"CardioFocus","sponsor_slug":"cardiofocus","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03004287","publication_url":"https://clinicaltrials.gov/study/NCT03004287","title":"2015-12: A Phase II Study Exploring the Use of Early and Late Consolidation/Maintenance With Anti-CD38 (Protein) Monoclonal Antibody to Improve Progression Free Survival in Patients With Newly Diagnosed Multiple Myeloma","has_exemption":false,"start_date":"2017-07-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Arkansas","sponsor_slug":"university-of-arkansas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03178552","publication_url":"https://clinicaltrials.gov/study/NCT03178552","title":"A Phase II/III Multicenter Study Evaluating the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Somatic Mutations Detected in Blood (B-FAST: Blood-First Assay Screening Trial)","has_exemption":false,"start_date":"2017-09-22","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03315910","publication_url":"https://clinicaltrials.gov/study/NCT03315910","title":"Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites","has_exemption":false,"start_date":"2017-10-10","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03323463","publication_url":"https://clinicaltrials.gov/study/NCT03323463","title":"A Prospective Single Arm Non-inferiority Trial of Major Radiation Dose De-Escalation Concurrent With Chemotherapy for Human Papilloma Virus Associated Oropharyngeal Carcinoma (Major De-escalation to 30Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma)","has_exemption":false,"start_date":"2017-10-16","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03315026","publication_url":"https://clinicaltrials.gov/study/NCT03315026","title":"Phase II Study of Interleukin 6 Blockade With Siltuximab to Decrease Symptom Burden in Patients Age 60-75 Undergoing Autologous Stem Cell Transplantation for Multiple Myeloma and AL Amyloidosis","has_exemption":false,"start_date":"2017-12-14","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03090165","publication_url":"https://clinicaltrials.gov/study/NCT03090165","title":"A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination With Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BRE15-024","has_exemption":false,"start_date":"2018-05-07","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Kari Wisinski","sponsor_slug":"kari-wisinski","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03716167","publication_url":"https://clinicaltrials.gov/study/NCT03716167","title":"Randomized Controlled Trial for Treatment of Pain and Assessment of Wound Healing in Chronic Venous Leg Ulcers","has_exemption":false,"start_date":"2018-07-27","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03693014","publication_url":"https://clinicaltrials.gov/study/NCT03693014","title":"A Phase II Trial of Hypofractionated Radiotherapy in Patients With Limited Progression on Immune Checkpoint Blockade","has_exemption":false,"start_date":"2018-10-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03716817","publication_url":"https://clinicaltrials.gov/study/NCT03716817","title":"Clinical Evaluation of Chairside CAD/CAM Resilient Ceramic Crowns","has_exemption":false,"start_date":"2018-10-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03705234","publication_url":"https://clinicaltrials.gov/study/NCT03705234","title":"HPS-4/TIMI 65/ORION-4: A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease","has_exemption":false,"start_date":"2018-10-30","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Oxford","sponsor_slug":"university-of-oxford","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03607890","publication_url":"https://clinicaltrials.gov/study/NCT03607890","title":"Phase 2 Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor","has_exemption":false,"start_date":"2018-11-16","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03183895","publication_url":"https://clinicaltrials.gov/study/NCT03183895","title":"Safety and Performance Evaluation of the AccuCinch® Ventricular Restoration System for the Treatment of Heart Failure With or Without Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study","has_exemption":false,"start_date":"2019-01-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Ancora Heart, Inc.","sponsor_slug":"ancora-heart-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04258462","publication_url":"https://clinicaltrials.gov/study/NCT04258462","title":"Hyperpolarized 13C Pyruvate Metabolic MRI to Predict Renal Tumor Aggressiveness","has_exemption":false,"start_date":"2019-01-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Zhen Wang, MD","sponsor_slug":"zhen-wang-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03513939","publication_url":"https://clinicaltrials.gov/study/NCT03513939","title":"A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation","has_exemption":false,"start_date":"2019-02-07","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Sernova Biotherapeutics Inc.","sponsor_slug":"sernova-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03823534","publication_url":"https://clinicaltrials.gov/study/NCT03823534","title":"Post-Op Pain Control for Prophylactic Intramedullary Nailing.","has_exemption":false,"start_date":"2019-02-20","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"St. Louis University","sponsor_slug":"st-louis-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03184454","publication_url":"https://clinicaltrials.gov/study/NCT03184454","title":"Combined Cortical and Subcortical Recording and Stimulation as a Circuit-Oriented Treatment for Obsessive-Compulsive Disorder","has_exemption":false,"start_date":"2019-03-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03737292","publication_url":"https://clinicaltrials.gov/study/NCT03737292","title":"Comparison of Plasma Concentration And Efficacy Of Liposomal Bupivacaine And Plain Bupivacaine After Intercostal Injections For Pain Management After Thoracoscopy","has_exemption":false,"start_date":"2019-04-09","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Milton S. Hershey Medical Center","sponsor_slug":"milton-s-hershey-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03922724","publication_url":"https://clinicaltrials.gov/study/NCT03922724","title":"Phase II Trial of Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma","has_exemption":false,"start_date":"2019-04-18","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03968822","publication_url":"https://clinicaltrials.gov/study/NCT03968822","title":"The Use of Intralipid® 20% Solution to Reverse the Anesthetic Effect of Local Anesthetics: a Proof of Concept Study in Volunteers","has_exemption":false,"start_date":"2019-07-26","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03994796","publication_url":"https://clinicaltrials.gov/study/NCT03994796","title":"Genomically-Guided Treatment Trial in Brain Metastases","has_exemption":false,"start_date":"2019-10-17","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04143516","publication_url":"https://clinicaltrials.gov/study/NCT04143516","title":"Clinical Trial Optimizing Tumor Ablation for Liver Metastases: Rapid Tissue Analysis Allowing for Immediate Retreatment; Metabolic Imaging Biomarker Validation; and Predictive Genetic Signatures","has_exemption":false,"start_date":"2019-10-25","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04148430","publication_url":"https://clinicaltrials.gov/study/NCT04148430","title":"A Phase II Study of IL-1 Receptor Antagonist Anakinra to Prevent Severe Neurotoxicity and Cytokine Release Syndrome in Patients Receiving CD19-Specific Chimeric Antigen Receptor (CAR) T Cells","has_exemption":false,"start_date":"2019-10-30","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04182997","publication_url":"https://clinicaltrials.gov/study/NCT04182997","title":"Subjective Intraoperative Use of Epidural Steroid Administration Following Discectomy for Herniated Lumbar Discs Is There a Role? - A Randomized Control Trial","has_exemption":false,"start_date":"2019-11-21","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04047628","publication_url":"https://clinicaltrials.gov/study/NCT04047628","title":"A Multicenter Randomized Controlled Trial of Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Treatment-Resistant Relapsing Multiple Sclerosis (ITN077AI)","has_exemption":false,"start_date":"2019-12-19","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04129502","publication_url":"https://clinicaltrials.gov/study/NCT04129502","title":"A Randomized Phase 3 Multicenter Open-Label Study to Compare the Efficacy of TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations","has_exemption":false,"start_date":"2020-01-10","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04218617","publication_url":"https://clinicaltrials.gov/study/NCT04218617","title":"Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases","has_exemption":false,"start_date":"2020-02-07","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Case Comprehensive Cancer Center","sponsor_slug":"case-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04262466","publication_url":"https://clinicaltrials.gov/study/NCT04262466","title":"Phase 1/2 Study of IMC-F106C in Advance PRAME-Positive Cancers","has_exemption":false,"start_date":"2020-02-25","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Immunocore Ltd","sponsor_slug":"immunocore-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04115514","publication_url":"https://clinicaltrials.gov/study/NCT04115514","title":"PHASE II RANDOMIZED, INTERVENTION VERSUS NON- INTERVENTION, MULTI- CENTER STUDY OF THE EFFECTS OF THYROID HORMONE (T3) ON SAFETY/TOLERABILITY AND OXYGENATION IN SUBJECTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)","has_exemption":false,"start_date":"2020-03-30","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03992430","publication_url":"https://clinicaltrials.gov/study/NCT03992430","title":"A Randomized, Double-Blind, Dose Finding and Comparison Study of the Safety and Efficacy of High Doses of Eteplirsen, Preceded by an Open-label Dose Escalation, in Patients With Duchenne Muscular Dystrophy With Deletion Mutations Amenable to Exon 51 Skipping","has_exemption":false,"start_date":"2020-07-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Sarepta Therapeutics, Inc.","sponsor_slug":"sarepta-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03832361","publication_url":"https://clinicaltrials.gov/study/NCT03832361","title":"A Phase II Evaluation of the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Persistent or Recurrent Endometrial Cancer","has_exemption":false,"start_date":"2020-07-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Alessandro Santin","sponsor_slug":"alessandro-santin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04299191","publication_url":"https://clinicaltrials.gov/study/NCT04299191","title":"Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors","has_exemption":false,"start_date":"2020-09-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Laminar Pharmaceuticals","sponsor_slug":"laminar-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04262141","publication_url":"https://clinicaltrials.gov/study/NCT04262141","title":"Investigator-Initiated Trial of the LSD1 Inhibitor IMG-7289 for the Treatment of Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV) That Have Failed at Least One Standard Therapy","has_exemption":false,"start_date":"2020-10-02","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Terrence J Bradley, MD","sponsor_slug":"terrence-j-bradley-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04623801","publication_url":"https://clinicaltrials.gov/study/NCT04623801","title":"Pilot Study to Evaluate the Safety and Efficacy of Percutaneous Laser Ablation of Thyroid Papillary Microcarcinoma","has_exemption":false,"start_date":"2020-10-19","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04715958","publication_url":"https://clinicaltrials.gov/study/NCT04715958","title":"Monitoring Neoadjuvant Chemotherapy of Breast Cancer Using 3D Subharmonic Aided Pressure Estimation","has_exemption":false,"start_date":"2020-12-07","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Kibo Nam","sponsor_slug":"kibo-nam","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04746235","publication_url":"https://clinicaltrials.gov/study/NCT04746235","title":"A Phase 2 Study of Venetoclax in Combination With ASTX727 in Patients With Relapsed/Refractory Acute Myeloid Leukemia, and Newly Diagnosed Elderly Patients With AML Who Are Not Candidates for Intensive Chemotherapy","has_exemption":false,"start_date":"2021-02-22","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04103476","publication_url":"https://clinicaltrials.gov/study/NCT04103476","title":"Atherosclerosis Intervention With Novel Tissue Selective Estrogen Complex Therapy","has_exemption":false,"start_date":"2021-04-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04965493","publication_url":"https://clinicaltrials.gov/study/NCT04965493","title":"A Phase 3 Open-Label, Randomized Study of Fixed Duration Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab Versus Venetoclax and Rituximab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-322)","has_exemption":false,"start_date":"2021-09-20","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Loxo Oncology, Inc.","sponsor_slug":"loxo-oncology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05343598","publication_url":"https://clinicaltrials.gov/study/NCT05343598","title":"Empirical Validation of a Cerebellar-cortical Hallucination Circuit","has_exemption":false,"start_date":"2021-10-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Mclean Hospital","sponsor_slug":"mclean-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05120934","publication_url":"https://clinicaltrials.gov/study/NCT05120934","title":"A Randomized, Double-blind, Placebo Controlled, Dose Escalation Pilot Study Evaluating the Efficacy of Two Doses of Duloxetine and Amitriptyline in Interstitial Lung Disease-related Cough","has_exemption":false,"start_date":"2021-11-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05117827","publication_url":"https://clinicaltrials.gov/study/NCT05117827","title":"Pediatric Powered Wheelchair Standing Devices: An Exploratory Study","has_exemption":false,"start_date":"2021-11-12","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Grand Valley State University","sponsor_slug":"grand-valley-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05119179","publication_url":"https://clinicaltrials.gov/study/NCT05119179","title":"Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes","has_exemption":false,"start_date":"2021-11-22","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05172726","publication_url":"https://clinicaltrials.gov/study/NCT05172726","title":"A Phase 3 Study of Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects","has_exemption":false,"start_date":"2021-12-02","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Organon and Co","sponsor_slug":"organon-and-co","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05090722","publication_url":"https://clinicaltrials.gov/study/NCT05090722","title":"A Pilot Study to Evaluate PureWick for Nocturia","has_exemption":false,"start_date":"2021-12-16","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05407636","publication_url":"https://clinicaltrials.gov/study/NCT05407636","title":"A Randomized, Partially Masked, Controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants With nAMD","has_exemption":false,"start_date":"2022-01-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05365646","publication_url":"https://clinicaltrials.gov/study/NCT05365646","title":"Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device","has_exemption":false,"start_date":"2022-05-23","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05425004","publication_url":"https://clinicaltrials.gov/study/NCT05425004","title":"A Phase II Study of Cabozantinib for Patients With Recurrent or Progressive Meningioma","has_exemption":false,"start_date":"2022-06-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Baptist Health South Florida","sponsor_slug":"baptist-health-south-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05405595","publication_url":"https://clinicaltrials.gov/study/NCT05405595","title":"A Phase 1b/2, Open-Label, Dose Escalation and Expansion Study of ADG126 in Combination With Pembrolizumab (Anti PD-1 Antibody) in Patients With Advanced/Metastatic Solid Tumors","has_exemption":false,"start_date":"2022-06-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Adagene Inc","sponsor_slug":"adagene-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04788043","publication_url":"https://clinicaltrials.gov/study/NCT04788043","title":"A Phase 2 Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma","has_exemption":false,"start_date":"2022-06-21","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05139277","publication_url":"https://clinicaltrials.gov/study/NCT05139277","title":"Clinical Investigation to Evaluate the CONVIVO System for Discrimination of Normal From Abnormal Tissue During Brain Tumor Resection","has_exemption":false,"start_date":"2022-06-28","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05073419","publication_url":"https://clinicaltrials.gov/study/NCT05073419","title":"Arrhythmia Detection After Myocardial Infarction Trial","has_exemption":false,"start_date":"2022-08-09","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Samir Saba","sponsor_slug":"samir-saba","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05548296","publication_url":"https://clinicaltrials.gov/study/NCT05548296","title":"A Phase 2 Study of ACR-368 Therapy in Subjects With Endometrial Cancer","has_exemption":false,"start_date":"2022-08-29","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Acrivon Therapeutics","sponsor_slug":"acrivon-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05081245","publication_url":"https://clinicaltrials.gov/study/NCT05081245","title":"A Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD).","has_exemption":false,"start_date":"2022-09-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"MapLight Therapeutics","sponsor_slug":"maplight-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05336812","publication_url":"https://clinicaltrials.gov/study/NCT05336812","title":"Prospective Randomized Phase II Study of Acalabrutinib + Obinutuzumab or Venetoclax in Previously Untreated CLL","has_exemption":false,"start_date":"2022-09-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04414514","publication_url":"https://clinicaltrials.gov/study/NCT04414514","title":"Exploratory Trial of Ruxolitinib 1.5% Cream for the Treatment of Early Stage Hidradenitis Suppurativa","has_exemption":false,"start_date":"2022-10-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Milton S. Hershey Medical Center","sponsor_slug":"milton-s-hershey-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04991025","publication_url":"https://clinicaltrials.gov/study/NCT04991025","title":"Phase 2 Trial of Neoadjuvant Nivolumab + Platinum-based Chemotherapy + Certolizumab in Patients With Resectable Stages II-III Lung Cancers","has_exemption":false,"start_date":"2022-10-19","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05554172","publication_url":"https://clinicaltrials.gov/study/NCT05554172","title":"Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders","has_exemption":false,"start_date":"2022-12-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05648500","publication_url":"https://clinicaltrials.gov/study/NCT05648500","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of Cenerimod in Adult Subjects With Moderate-to-Severe Systemic Lupus Erythematosus (SLE) on Top of Background Therapy","has_exemption":false,"start_date":"2022-12-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Viatris Innovation GmbH","sponsor_slug":"viatris-innovation-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05030545","publication_url":"https://clinicaltrials.gov/study/NCT05030545","title":"Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical Study","has_exemption":false,"start_date":"2022-12-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05592626","publication_url":"https://clinicaltrials.gov/study/NCT05592626","title":"A Phase 1/2, First-in-Human, Open-Label, Dose Escalation and Expansion Study of STAR0602, a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule, in Subjects With Unresectable, Locally Advanced, or Metastatic Solid Tumors That Are Antigen-rich (START-001)","has_exemption":false,"start_date":"2023-01-04","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Marengo Therapeutics, Inc.","sponsor_slug":"marengo-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05751941","publication_url":"https://clinicaltrials.gov/study/NCT05751941","title":"A Phase II Randomized Study of Sipuleucel-T With or Without Continuing New Hormonal Agents (NHA) in Metastatic Prostate Cancer With PSA Progression While on NHA and LHRH Analog","has_exemption":false,"start_date":"2023-02-14","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05747924","publication_url":"https://clinicaltrials.gov/study/NCT05747924","title":"A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of AOC 1020 Administered Intravenously to Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)","has_exemption":false,"start_date":"2023-04-04","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Avidity Biosciences, Inc.","sponsor_slug":"avidity-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05795465","publication_url":"https://clinicaltrials.gov/study/NCT05795465","title":"A Phase 2, Two-Part Study to Evaluate the Safety and Tolerability of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)","has_exemption":false,"start_date":"2023-04-04","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"GEn1E Lifesciences","sponsor_slug":"gen1e-lifesciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05757869","publication_url":"https://clinicaltrials.gov/study/NCT05757869","title":"A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active-Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants With Atrial Fibrillation","has_exemption":false,"start_date":"2023-04-11","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05746546","publication_url":"https://clinicaltrials.gov/study/NCT05746546","title":"Open Label Extension Study of Depressed Mood Improvement Through Nicotine (Depressed MIND3)","has_exemption":false,"start_date":"2023-04-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05805501","publication_url":"https://clinicaltrials.gov/study/NCT05805501","title":"A Randomized Open Label Phase II Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma","has_exemption":false,"start_date":"2023-04-21","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05716100","publication_url":"https://clinicaltrials.gov/study/NCT05716100","title":"A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures","has_exemption":false,"start_date":"2023-05-09","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Xenon Pharmaceuticals Inc.","sponsor_slug":"xenon-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05804084","publication_url":"https://clinicaltrials.gov/study/NCT05804084","title":"Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea","has_exemption":false,"start_date":"2023-05-16","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05747794","publication_url":"https://clinicaltrials.gov/study/NCT05747794","title":"AIPAC-003 (Active Immunotherapy and PAClitaxel): a Randomized, Double-blind, Placebo-controlled Phase 3 Trial Testing Eftilagimod Alpha (soluble LAG-3) in HER2-neg/low Metastatic Breast Cancer Patients Receiving Paclitaxel, Following an Open-label Dose Optimization","has_exemption":false,"start_date":"2023-05-22","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Immutep S.A.S.","sponsor_slug":"immutep-sas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05672576","publication_url":"https://clinicaltrials.gov/study/NCT05672576","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of Cenerimod in Adult Subjects With Moderate-to-severe Systemic Lupus Erythematosus (SLE) on Top of Background Therapy","has_exemption":false,"start_date":"2023-06-26","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Viatris Innovation GmbH","sponsor_slug":"viatris-innovation-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05741060","publication_url":"https://clinicaltrials.gov/study/NCT05741060","title":"Arterial Stiffness, Cognition and Equol","has_exemption":false,"start_date":"2023-06-29","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Akira Sekikawa","sponsor_slug":"akira-sekikawa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05669833","publication_url":"https://clinicaltrials.gov/study/NCT05669833","title":"Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients: a Pragmatic Trial (EVOLUTION)","has_exemption":false,"start_date":"2023-07-14","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05852691","publication_url":"https://clinicaltrials.gov/study/NCT05852691","title":"A Phase II, Multicenter, Randomized, Double-Blind Study of Tobemstomig/RO7247669 Combined With Nab-Paclitaxel Compared With Pembrolizumab Combined With Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer","has_exemption":false,"start_date":"2023-07-18","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06052267","publication_url":"https://clinicaltrials.gov/study/NCT06052267","title":"A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma","has_exemption":false,"start_date":"2023-08-30","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Teva Branded Pharmaceutical Products R&D LLC","sponsor_slug":"teva-branded-pharmaceutical-products-rd-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05734560","publication_url":"https://clinicaltrials.gov/study/NCT05734560","title":"Delivery of D2C7-IT and 2141-V11 Combination Immunotherapy in Residual Disease for Adult Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma and Perilymphatic Subcutaneous Injections of 2141-V11","has_exemption":false,"start_date":"2023-09-06","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Darell Bigner","sponsor_slug":"darell-bigner","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05908084","publication_url":"https://clinicaltrials.gov/study/NCT05908084","title":"A Phase 3 Randomized Study to Compare the Efficacy and Safety of the Humacyte Acellular Tissue Engineered Vessel (ATEV) With That of an Autogenous Arteriovenous Fistula (AVF) in Female Patients With End-Stage Renal Disease Requiring Hemodialysis","has_exemption":false,"start_date":"2023-09-07","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Humacyte, Inc.","sponsor_slug":"humacyte-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06057922","publication_url":"https://clinicaltrials.gov/study/NCT06057922","title":"A Multicenter, Open-Label, Phase 1/2 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With Selected Advanced Solid Tumors","has_exemption":false,"start_date":"2023-09-22","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"MediLink Therapeutics (Suzhou) Co., Ltd.","sponsor_slug":"medilink-therapeutics-suzhou-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05417165","publication_url":"https://clinicaltrials.gov/study/NCT05417165","title":"Phase II Comparative Study of Anti-Pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia","has_exemption":false,"start_date":"2023-09-29","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Seema Bhat","sponsor_slug":"seema-bhat","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05369520","publication_url":"https://clinicaltrials.gov/study/NCT05369520","title":"Non-invasive Spinal Cord Stimulation for Recovery of Autonomic Function After Spinal Cord Injury: Moving From Mechanisms to Clinical Practice","has_exemption":false,"start_date":"2023-10-03","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of British Columbia","sponsor_slug":"university-of-british-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05804669","publication_url":"https://clinicaltrials.gov/study/NCT05804669","title":"A Phase 1b/2a Open-label Multiple-ascending Dose Exploratory Study of CRN04894 in ACTH-dependent Cushing's Syndrome (Cushing's Disease or Ectopic ACTH Syndrome)","has_exemption":false,"start_date":"2023-10-12","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Crinetics Pharmaceuticals Inc.","sponsor_slug":"crinetics-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05318469","publication_url":"https://clinicaltrials.gov/study/NCT05318469","title":"A Phase I/II Study Evaluating the Safety and Efficacy of Ivermectin in Combination With Immune Checkpoint Inhibitor in Patients With Metastatic Triple Negative Breast Cancer","has_exemption":false,"start_date":"2023-10-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Yuan Yuan","sponsor_slug":"yuan-yuan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06083922","publication_url":"https://clinicaltrials.gov/study/NCT06083922","title":"A Phase II Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab for Patients With Monoclonal Gammopathy of Renal Significance (MGRS)","has_exemption":false,"start_date":"2023-10-16","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05598333","publication_url":"https://clinicaltrials.gov/study/NCT05598333","title":"A Phase 2, Adaptive, Double-blinded, Placebo Controlled, Randomized, Multi-center Trial to Evaluate the Efficacy, Safety and Tolerability of Intracoronary Infusion of AB-1002 in Adult Subjects With New York Heart Association (NYHA) Class III Heart Failure and Non-ischemic Cardiomyopathy","has_exemption":false,"start_date":"2023-10-20","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"AskBio Inc","sponsor_slug":"askbio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05715619","publication_url":"https://clinicaltrials.gov/study/NCT05715619","title":"A Phase 1/2a Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Safety and Efficacy of Oral Administration of the Phage Cocktail, VRELysin™, In Healthy And VRE-Colonized Subjects","has_exemption":false,"start_date":"2023-10-25","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Intralytix, Inc.","sponsor_slug":"intralytix-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06162728","publication_url":"https://clinicaltrials.gov/study/NCT06162728","title":"A Phase 1b/2a, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines and/or Omalizumab, or Who Cannot Tolerate Omalizumab","has_exemption":false,"start_date":"2023-11-29","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Jasper Therapeutics, Inc.","sponsor_slug":"jasper-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05561114","publication_url":"https://clinicaltrials.gov/study/NCT05561114","title":"Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus","has_exemption":false,"start_date":"2023-12-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"GIE Medical","sponsor_slug":"gie-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06223659","publication_url":"https://clinicaltrials.gov/study/NCT06223659","title":"Investigating the Use of EMLA Topical Cream for Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Cutaneous Cancers","has_exemption":false,"start_date":"2023-12-19","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06077227","publication_url":"https://clinicaltrials.gov/study/NCT06077227","title":"Immersive Healing: The Therapeutic Potential of Virtual Reality in Phantom Limb Experience","has_exemption":false,"start_date":"2023-12-21","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05983250","publication_url":"https://clinicaltrials.gov/study/NCT05983250","title":"A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary Hypertension Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction (PH-HFpEF)","has_exemption":false,"start_date":"2024-01-10","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Tenax Therapeutics, Inc.","sponsor_slug":"tenax-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05886036","publication_url":"https://clinicaltrials.gov/study/NCT05886036","title":"NORM: Nodular Lymphocyte-Predominant Hodgkin Lymphoma Patients Treated in a Randomized Phase 2 Trial With Either Rituximab or Mosunetuzumab","has_exemption":false,"start_date":"2024-01-23","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06232655","publication_url":"https://clinicaltrials.gov/study/NCT06232655","title":"Study of Cladribine+Venetoclax After Failure of Venetoclax+Hypomethylating Agent in Monocytic AML","has_exemption":false,"start_date":"2024-02-08","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06335173","publication_url":"https://clinicaltrials.gov/study/NCT06335173","title":"A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Intravenous Sabirnetug in Early Alzheimer's Disease","has_exemption":false,"start_date":"2024-02-29","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Acumen Pharmaceuticals","sponsor_slug":"acumen-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04003506","publication_url":"https://clinicaltrials.gov/study/NCT04003506","title":"Comparing the Efficacy of Combining Periarticular Local Infiltration of Analgesia and Adductor Canal Block Using Liposomal Bupivacaine and Standard Bupivacaine in Total Knee Arthroplasty - A Prospective Randomized Controlled Trial","has_exemption":false,"start_date":"2024-03-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"The University of Hong Kong","sponsor_slug":"the-university-of-hong-kong","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06266338","publication_url":"https://clinicaltrials.gov/study/NCT06266338","title":"A Phase 2A, Prospective, Open Label, Single Institution Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)","has_exemption":false,"start_date":"2024-03-11","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06133114","publication_url":"https://clinicaltrials.gov/study/NCT06133114","title":"Psychopharmacological Treatment of Emotional Distress: A Randomized Controlled Trial","has_exemption":false,"start_date":"2024-03-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06297603","publication_url":"https://clinicaltrials.gov/study/NCT06297603","title":"A Phase 3, Randomized, Multicenter, Double-Blind Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared With Placebo in Adult Participants With Type 2 Diabetes, Moderate or Severe Renal Impairment With Inadequate Glycemic Control on Basal Insulin With or Without Metformin and/or SGLT2 Inhibitor","has_exemption":false,"start_date":"2024-03-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06273553","publication_url":"https://clinicaltrials.gov/study/NCT06273553","title":"An Open-Label, Phase 1/2 Study to Evaluate the Safety, Tolerability, Immunogenicity and Efficacy of RG002 Injection (an mRNA Therapeutic Vaccine) in Subjects With Human Papillomavirus (HPV) 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3 (CIN2/3)","has_exemption":false,"start_date":"2024-03-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"RinuaGene Biotechnology Co., Ltd.","sponsor_slug":"rinuagene-biotechnology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06179004","publication_url":"https://clinicaltrials.gov/study/NCT06179004","title":"Randomized Controlled Trial of Supraclavicular Bupivacaine Vs. Supraclavicular Liposomal Bupivacaine for Orthopedic Wrist Surgery","has_exemption":false,"start_date":"2024-04-10","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06125951","publication_url":"https://clinicaltrials.gov/study/NCT06125951","title":"A Phase 2b/3, Double-Blind, Placebo-Controlled, Parallel-Group, 36-Week, 2-Arm Trial With an Open-Label Extension Phase to Assess the Safety, Tolerability, and Efficacy of Xanamem® 10 mg Daily in Patients With Mild or Moderate Dementia Due to Alzheimer's Disease","has_exemption":false,"start_date":"2024-04-12","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Actinogen Medical","sponsor_slug":"actinogen-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06136585","publication_url":"https://clinicaltrials.gov/study/NCT06136585","title":"Comparison of Efficacy of Sugammadex Versus Neostigmine in Reversing Neuromuscular Blocks in Patients Having Outpatient Endoscopic Retrograde Cholangiopancreatography (ERCP). A Randomized, Double-Blinded Trial","has_exemption":false,"start_date":"2024-06-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06363877","publication_url":"https://clinicaltrials.gov/study/NCT06363877","title":"Wound Irrigation and Peritoneal Lavage With Diluted Aqueous Povidone-Iodine Compared to Saline to Decrease Surgical Site Infections","has_exemption":false,"start_date":"2024-06-03","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Loma Linda University","sponsor_slug":"loma-linda-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06463158","publication_url":"https://clinicaltrials.gov/study/NCT06463158","title":"A Phase I Clinical Trial Evaluating the Impact of the Family Room App on Caregiver Well-being, Satisfaction, and Engagement in the Intensive Care Unit","has_exemption":false,"start_date":"2024-07-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06325566","publication_url":"https://clinicaltrials.gov/study/NCT06325566","title":"A Prospective, Multicenter, Randomized, Double-blind, Controlled Study to Evaluate the Efficacy and Safety of a Single Injection of Rexlemestrocel-L Combined With HA in Subjects With Moderate to Severe Chronic Low Back Pain","has_exemption":false,"start_date":"2024-07-03","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Mesoblast, Ltd.","sponsor_slug":"mesoblast-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06445023","publication_url":"https://clinicaltrials.gov/study/NCT06445023","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab in Patients With Chronic Spontaneous Urticaria Who Remain Symptomatic Despite H1 Antihistamine Treatment (EMBARQ-CSU1)","has_exemption":false,"start_date":"2024-07-11","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Celldex Therapeutics","sponsor_slug":"celldex-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06455202","publication_url":"https://clinicaltrials.gov/study/NCT06455202","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab in Patients With Chronic Spontaneous Urticaria Who Remain Symptomatic Despite H1 Antihistamine Treatment (EMBARQ-CSU2)","has_exemption":false,"start_date":"2024-07-19","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Celldex Therapeutics","sponsor_slug":"celldex-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06560307","publication_url":"https://clinicaltrials.gov/study/NCT06560307","title":"Examination of Programming with the Enterra® Therapy System in a Double-Blinded, Randomized, Prospective Study in the Treatment of Nausea and Vomiting Symptoms Using Gastric Electrical Stimulation","has_exemption":false,"start_date":"2024-07-25","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Enterra Medical, Inc.","sponsor_slug":"enterra-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06510816","publication_url":"https://clinicaltrials.gov/study/NCT06510816","title":"A Phase 3, Multicenter, Randomized, Parallel-Group, Double-Masked, 2-Arm, Sham Controlled Study of the Efficacy, Safety, and Tolerability of ANX007 Administered by Intravitreal Injection in Patients With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)","has_exemption":false,"start_date":"2024-07-30","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Annexon, Inc.","sponsor_slug":"annexon-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06129539","publication_url":"https://clinicaltrials.gov/study/NCT06129539","title":"LIBELULA™: An Open-label, Single-arm, Multi-center, Phase 3 Study on the Efficacy, Safety, and Pharmacokinetics of Debio 4326, a Triptorelin 12-month Formulation, in Pediatric Participants With Central Precocious Puberty","has_exemption":false,"start_date":"2024-07-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Debiopharm International SA","sponsor_slug":"debiopharm-international-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06524375","publication_url":"https://clinicaltrials.gov/study/NCT06524375","title":"Phase II, Open-label, Prospective Single-arm, Multi-center Clinical Trial to Evaluate if Adding Venetoclax to Patients on Covalent BTKi For 1L CLL Can Achieve Deep Durable Remissions (by UMRD 10^-4) to Allow Off-treatment Period","has_exemption":false,"start_date":"2024-08-09","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Genentech, Inc.","sponsor_slug":"genentech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06446752","publication_url":"https://clinicaltrials.gov/study/NCT06446752","title":"A Phase 3 Randomized, Observer-Blind, Placebo-Controlled Study to Assess Efficacy of Meningococcal Group B (rMenB+OMV NZ (Bexsero)) in Preventing Gonococcal Infection Among South African Cis-Gender Women","has_exemption":false,"start_date":"2024-08-14","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05868330","publication_url":"https://clinicaltrials.gov/study/NCT05868330","title":"A Feasibility Randomized Control Comparison of Peripheral Interscalene Catheter to Liposomal Bupivacaine Single Injection for Interscalene Blocks Used in Pain Control for Total Shoulder Arthroplasties","has_exemption":false,"start_date":"2024-08-19","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Melinda Seering","sponsor_slug":"melinda-seering","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06055790","publication_url":"https://clinicaltrials.gov/study/NCT06055790","title":"Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis","has_exemption":false,"start_date":"2024-09-10","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06593067","publication_url":"https://clinicaltrials.gov/study/NCT06593067","title":"Skin Surface and Intradermal Temperature Responses to Heat Stress","has_exemption":false,"start_date":"2024-10-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null}]}